174 related articles for article (PubMed ID: 34324714)
1. PTEN expression and morphological patterns in prostatic adenocarcinoma.
Spieker AJ; Gordetsky JB; Maris AS; Dehan LM; Denney JE; Arnold Egloff SA; Scarpato K; Barocas DA; Giannico GA
Histopathology; 2021 Dec; 79(6):1061-1071. PubMed ID: 34324714
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
Downes MR; Satturwar S; Trudel D; van der Kwast TH
Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
[TBL] [Abstract][Full Text] [Related]
4. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027
[TBL] [Abstract][Full Text] [Related]
5. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).
Shah RB; Shore KT; Yoon J; Mendrinos S; McKenney JK; Tian W
Prostate; 2019 Aug; 79(11):1267-1273. PubMed ID: 31111513
[TBL] [Abstract][Full Text] [Related]
6. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.
Kweldam CF; Wildhagen MF; Steyerberg EW; Bangma CH; van der Kwast TH; van Leenders GJ
Mod Pathol; 2015 Mar; 28(3):457-64. PubMed ID: 25189638
[TBL] [Abstract][Full Text] [Related]
7. Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
Kweldam CF; Kümmerlin IP; Nieboer D; Steyerberg EW; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ
Mod Pathol; 2017 Aug; 30(8):1126-1132. PubMed ID: 28530220
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
Ronen S; Abbott DW; Kravtsov O; Abdelkader A; Xu Y; Banerjee A; Iczkowski KA
Hum Pathol; 2017 Jul; 65():85-91. PubMed ID: 28504208
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
Lotan TL; Gumuskaya B; Rahimi H; Hicks JL; Iwata T; Robinson BD; Epstein JI; De Marzo AM
Mod Pathol; 2013 Apr; 26(4):587-603. PubMed ID: 23222491
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
[TBL] [Abstract][Full Text] [Related]
11. 'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis.
Bogaard M; Skotheim RI; Maltau AV; Kidd SG; Lothe RA; Axcrona K; Axcrona U
Histopathology; 2023 Dec; 83(6):853-869. PubMed ID: 37501635
[TBL] [Abstract][Full Text] [Related]
12. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.
Hansum T; Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Remmers S; van Leenders GJLH
Mod Pathol; 2021 Nov; 34(11):2064-2070. PubMed ID: 34175896
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer.
Flood TA; Schieda N; Sim J; Breau RH; Morash C; Belanger EC; Robertson SJ
Virchows Arch; 2018 Feb; 472(2):205-212. PubMed ID: 28975495
[TBL] [Abstract][Full Text] [Related]
14. PTEN Loss and PD-L1 Expression of Different Histological Patterns of Prostate Cancer.
Kir G; Cecikoglu GE; Olgun ZC; Kazan HO; Yildirim A
Pathol Res Pract; 2022 Jan; 229():153738. PubMed ID: 34922209
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics of glomeruloid architecture in prostate cancer.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Roobol MJ; van Leenders GJLH
Mod Pathol; 2020 Aug; 33(8):1618-1625. PubMed ID: 32080350
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer.
Kim SH; Kim SH; Joung JY; Lee GK; Hong EK; Kang KM; Yu A; Nam BH; Chung J; Seo HK; Park WS; Lee KH
PLoS One; 2015; 10(4):e0122498. PubMed ID: 25897494
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
[TBL] [Abstract][Full Text] [Related]
18. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4.
Chen Z; Pham H; Abreu A; Amin MB; Sherrod AE; Xiao GQ; Aron M
Hum Pathol; 2021 Dec; 118():18-29. PubMed ID: 34543668
[TBL] [Abstract][Full Text] [Related]
20. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Roobol MJ; van Leenders GJLH
Mod Pathol; 2021 Jan; 34(1):184-193. PubMed ID: 32686748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
